SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001171843-17-002415
Filing Date
2017-04-28
Accepted
2017-04-28 16:10:17
Documents
4
Period of Report
2017-06-13
Effectiveness Date
2017-04-28

Document Format Files

Seq Description Document Type Size
1 DEF 14A def14a_042817.htm DEF 14A 841062
2 GRAPHIC cheung_sig.jpg GRAPHIC 2020
3 GRAPHIC card_1.jpg GRAPHIC 142463
4 GRAPHIC card_2.jpg GRAPHIC 161932
  Complete submission text file 0001171843-17-002415.txt   1257107
Mailing Address 32 WIGGINS AVENUE BEDFORD MA 01730
Business Address 32 WIGGINS AVENUE BEDFORD MA 01730 (781) 457-9000
Anika Therapeutics, Inc. (Filer) CIK: 0000898437 (see all company filings)

IRS No.: 043145961 | State of Incorp.: MA | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-14027 | Film No.: 17795555
SIC: 3841 Surgical & Medical Instruments & Apparatus